Clinical innovations, Inc.

Riverside, California 92647

2 studies enrolling now · 17 studies all time

What they study most

Alzheimer Disease, Attention Deficit Hyperactivity Disorder, Bipolar Depression, Bipolar Disorder, Bipolar I Disorder, Bipolar II Disorder, Chronic Schizophrenia, Depressive Episodes, Bipolar I Depression, Insomnia, Major Depressive Disorder, Major Depressive Disorder With Mixed Features, Mild Cognitive Impairment

Studies at this site

• Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia — Recruiting now
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) — Recruiting now
• A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication — Completed
• A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) — Running, not enrolling
• A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression). — Stopped early
• A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder. — Stopped early
• Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus — Stopped early
• Safety and Efficacy of Cariprazine in Patients With Schizophrenia — Completed
• Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia — Completed
• Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose — Completed
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression — Completed
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. — Completed
• Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia — Completed
• Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) — Completed
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression — Completed
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia — Completed